Treatment of Alopecia Areata With Dupilumab
Last Updated:
01/07/2021
Status:
Completed
Country:
United States
Eligibility:
Age 18+; diagnosed with alopecia areata
Drug:
Dupilumab
Administration:
Injection
Sponsor:
Icahn School of Medicine at Mount Sinai
Link:
Researchers at The Rockefeller University are conducting a study to test an injectable treatment for alopecia areata.
You may be eligible if you:
- Are at least 18 years of age
- Have had moderate to severe alopecia areata (at least 30% hair loss) for at least 6 months
- Are willing to consider injectable treatment
- Do not have HIV
Participation includes:
- 16 visits over 18 months
- Receipt of study medication
- Blood work
- Skin biopsies (required)
Compensation will be provided.
If you are interested, please contact the Recruitment Office at 1-800-RUCARES (1-800-782-2737) or RUCARES@Rockefeller.edu.
Location:
The Rockefeller University
Laboratory for Investigative Dermatology
New York, New YorK